Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 5 | 3 | — | — | — | 6 |
Non-small-cell lung carcinoma | D002289 | — | — | 3 | 1 | — | — | — | 3 |
Neoplasms | D009369 | — | C80 | 2 | 2 | — | — | — | 3 |
Lung neoplasms | D008175 | — | C34.90 | 2 | 1 | — | — | — | 2 |
Adenocarcinoma | D000230 | — | — | 1 | 2 | — | — | — | 2 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 1 | — | — | — | 1 |
Esophageal neoplasms | D004938 | — | C15 | — | 1 | — | — | — | 1 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | — | 1 | — | — | — | 1 |
Rectal neoplasms | D012004 | — | — | — | 1 | — | — | — | 1 |
Sarcoma | D012509 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
Urologic neoplasms | D014571 | — | C64-C68 | 1 | — | — | — | — | 1 |
Head and neck neoplasms | D006258 | — | — | 1 | — | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | 1 | — | — | — | — | 1 |
Drug common name | SELICRELUMAB |
INN | selicrelumab |
Description | CP-870893 (mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2109477 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 0O39RGI33V (ChemIDplus, GSRS) |